AOD-9604
Also known as: Anti-Obesity Drug 9604
AOD-9604 is a 16-amino-acid synthetic peptide corresponding to the C-terminal fragment of human growth hormone (residues 177-191) with an additional N-terminal tyrosine. Developed by Metabolic Pharmaceuticals (Australia) to isolate a purported 'lipolytic' activity of GH without GH-receptor-mediated growth or diabetogenic effects. AOD-9604 is NOT FDA-approved for any indication; controlled human trials for obesity did not demonstrate clinically meaningful weight loss, and obesity development was terminated in 2007.
Pricing for AOD-9604
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
COAs for AOD-9604
60 third-party tests across 24 vendors. Each card links to the full report.
For
AOD-9604
by EZ Peptides· batch EZP-AOD205242026-04
For
AOD-9604
by Crush Research· batch R-AOD-5-2605-1
For
AOD-9604
by Prime Peptides· batch 4132026AD
For
AOD-9604
by Skye Peptides· batch AOD26-06-002
For
AOD-9604
by Ion Peptide· batch AOD5-05042026
For
AOD-9604
by Ion Peptide· batch AOD10-05042026
For
AOD-9604
by Ion Peptide· batch AOD10-04222026
For
AOD-9604
by Peptide Plugs· batch 112-U
For
AOD-9604
by Qihang Peptide· batch 4
For
AOD-9604
by OROS Research· batch OR-LPAOD5-326-B2
For
AOD-9604
by Amino Club· batch AOD0001
For
AOD9604
by Crush Research· batch CR-5AD5-2603-1
For
AOD-9604
by Ion Peptide· batch AOD5-03262026
For
AOD-9604
by Real Peptides· batch Black-Cap
For
AOD-9604
by Mile High Compounds· batch AOD-005-MH-02
For
AOD-9604
by Qihang Peptide· batch 3
For
AOD-9604
by Simple Peptide· batch AOD05-032026-1
For
AOD-9604
by Profound Aminos· batch cmojb83ng01glkirxfqo2n823
For
AOD-9604
by Peptidology· batch 1671
For
AOD-9604
by Peptide Supply Co.· batch AOD1022026
For
AOD-9604
by Cocer Peptides· batch CS-ad5-0202
For
AOD-9604
by Simple Peptide· batch AOD0128202G-J
For
AOD-9604
by Prime Peptides· batch 01062026
For
AOD-9604
by Moglabs
14 citations indexed for AOD-9604
Study · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.
review · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.
review · 2026
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.
review · 2026
Annual Banned-Substance Review 18th Edition-Analytical Approaches in Human Sports Drug Testing 2024/2025
Alongside the considerable advances and accomplishments in drug research and development, the breadth of anti-doping research topics has also continued to grow.
Study · 2025
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.
Study · 2025
Illegal and falsified medicines self-administrated in not approved post-cycle therapy after the cessation of anabolic-androgenic steroids - qualitative analysis
Background The term post-cycle therapy (PCT) often appears in bodybuilding forums in the context of anabolic-androgenic steroids (AAS) cessation. To reduce the negative impact of AAS on the hormonal system, unapproved PCT is used, which consist of medications that help restore hormonal balance.